Thursday, January 24, 2013

Toll Brothers - TOL - Barchart Chart of the Day


Barchart.com's Chart of the Day - Toll Brothers (TOL)
The "Chart of the Day" is Toll Brothers (TOL), which showed up on Wednesday's Barchart "52-Week High" list. Toll Brothers on Wednesday posted a new 7-year high and closed +2.07%. TrendSpotter has been long since Jan 3 at $33.39. In recent news on the stock, Bank of America/Merrill on Jan 10 reinstated research coverage on Toll Brothers with a Buy and a target of $42. Toll Brothers CEO told Bloomberg in an interview on Jan 23 that Toll Brothers is planning to expand into "high-end" college dorms. Toll Brothers, with a market cap of $6 billion, designs, builds, markets and arranges financing for single-family detached and attached homes in middle and high income residential communities in thirteen states and five regions around the country.

tol_700
We found the "Chart of the Day" by scanning the Barchart "52-week Highs" page. That page shows all the stocks that have posted new 52-week highs, which is a popular sign of strong upside momentum.
The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
  • TrendSpotter: Buy
  • Short-Term Indicators: 80% Buy
  • Medium-Term Indicators: 100% Buy
  • Long-Term Indicators: 33% Buy
  • Overall Average 80% Buy


Barchart links for further information:

Quotes and Charts
Quote
Detailed Quote
Chart

Technical Analysis
Technicals Summary
Trader's Cheat Sheet™

Barchart Opinions
Barchart Opinion
Barchart Snapshot
Trading Strategies

Company Info
Company Profile
Key Statistics
Ratios
Income Statement-Quarterly
Income Statement-Annual
Balance Sheet-Current
Balance Sheet-Annual


Chart of the Day Archive
View Past Chart of the Day Reports

No comments:

Post a Comment